Skip to main content
. 2020 Jun 17;86(11):2256–2265. doi: 10.1111/bcp.14328

FIGURE 3.

FIGURE 3

Annual notification rate of amoxicillin‐induced crystal nephropathy (AICN) per 100 000 patient‐years of exposure: (A) intravenous amoxicillin (AMX) and/or AMX–clavulanate (AMX‐CLAV; filled circle); (B) intravenous AMX (filled square); (C) intravenous AMX‐CLAV (open square)